How to streamline your clinical trial process to drive enrollment

One of the most critical steps in the clinical trial process is patient recruitment. Statistics show that approximately 80% of clinical trials are delayed or closed because of problems with recruitment. But without the right recruitment tools and strategies, clinical trial teams can’t find the volunteers that they need, ultimately slowing timelines. We outline three strategies to streamline your ...

Continue reading

How patient lead generation can accelerate clinical trial patient recruitment [patient recruitment case study]

Postoperative Corneal Induced Chronic Pain (also known as CICP) is a condition that causes chronic pain and blurred vision after eye surgery. For the 300,000 people who experience this, effective treatments could drastically improve their quality of life.

Continue reading

Clinical research in a post-COVID world: Four sites weigh in on the impact of COVID on the future of medical research [whitepaper]

Over the past year and a half, the traditional clinical research model of patient outreach, in-person screening, and site-based follow-up has had to adjust to drive progress while keeping patients safe. Now, with vaccines driving positivity rates down, we can begin to think about what’s next. Still, questions remain: Of all the changes made in the research industry since the beginning of the ...

Continue reading

Clinical trial recruitment tools that drive success

Clinical trial recruitment can be a difficult puzzle to solve. In fact, approximately 80% of clinical trials are delayed or closed because of problems with recruitment. However, with the right tools at your fingertips, finding the right patients for your studies can become a realistic goal. We share three clinical trial recruitment tools that drive success.

Continue reading

How a 67% randomization rate led to 3 months saved in a Parkinson’s trial [patient recruitment case study]

Parkinson’s disease is a disorder of the central nervous system that affects movement, with symptoms such as tremor, slow movement, stiffness, and loss of balance. Current treatments come with side effects, and there is no cure. This means research is critical to developing new and better treatments for the nearly one million people in the US living with Parkinson’s disease.

Continue reading

Big news: We’ve closed a $23M funding round to scale our digital patient engagement services

It’s a big day here at Antidote! We’re thrilled to announce the close of a $23.2M funding round, led by LBO France with contributions from existing investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures.

Continue reading

Three things to look for when hiring clinical trial recruitment companies

To help speed up timelines for clinical trials, sponsors hire recruitment companies to implement a range of outreach methods, including digital advertising and community partnerships, to find the right patients for a study. Most sites and sponsors evaluate proposals from a few different companies before making a selection, but when choosing a company, you should consider each company’s offerings ...

Continue reading

An app partnership to reach epilepsy patients for an AI study [case study]

For the 3.4 million Americans who live with active epilepsy, there is no cure. The hope is that seizures can be predicted and prevented, and there are many anti-epileptic medications that can assist with this. But, with various options available, it can be difficult to determine which treatment might be best for a patient. Creative approaches are necessary to provide the best outcomes for ...

Continue reading

5 metrics that clinical trial patient recruitment companies track

Whether you're running patient recruitment yourself or working with a clinical trial patient recruitment company, there are certain metrics you can track to ensure your campaign is running effectively.

Continue reading

Diversity and inclusion in clinical trials [one-page primer]

People of color have been (and continue to be) particularly underrepresented in clinical research. Historically, the numbers of clinical trial participants from diverse populations have not reflected real-world populations. The lack of diversity in clinical trials can make it particularly challenging to get a complete picture of a drug’s safety and efficacy. That’s why it’s critical that the ...

Continue reading

Get our latest posts in your inbox